Inactive Instrument

Geyser Brands Inc.

GYSR.H

CA3744031038

Geyser Brands Inc. announced that it has received $0.312109 million in funding

January 03, 2019

On January 3, 2019, Geyser Brands Inc. closed the transaction. The transaction included participation from 8 investors.

Latest news about Geyser Brands Inc.

Geyser Brands Inc. Announces Appointment of New Members to the Investigation Committee	18/22/18	CI
Geyser Brands Inc. Announces Changes to Board of Directors	31/21/31	CI
Geyser Brands Inc. Announces Changes in CEO	31/21/31	CI
Geyser Brands Inc. Announces Directorate Changes	27/21/27	CI
Geyser Brands Inc. Announces Resignations of Qiping Men and Zhefei Song as Directors	07/21/07	CI
Geyser Brands Inc. Announces Executive Changes	07/21/07	CI
Geyser Brands Inc. Announces Appointment of Lige Li as New Director	14/21/14	CI
Geyser Brands Inc. announced that it has received CAD 0.585 million in funding	23/21/23	CI
Geyser Brands Inc. Appoints Ms. Judy Hou as Director	07/21/07	CI
Geyser Brands Inc. announced that it expects to receive CAD 0.585 million in funding	17/21/17	CI
Geyser Brands Inc. Announces Director and Board Changes	04/20/04	CI
Geyser Brands Inc. Announces Executive Changes	06/20/06	CI
Geyser Brands Inc. Enters into Loan Agreement with an Arm's Length Private Lender for Secured Loan of Up to $1,000,000	06/20/06	CI
Geyser Brands Inc. Announces Board Appointments	23/20/23	CI
Geyser Brands Inc. Announces Resignation of Amir Abdollahzadeh as CFO	23/20/23	CI
Geyser Brands Inc. Announces Executive Changes	19/20/19	CI
Geyser Brands Inc. Appoints Amir Abdollahzadeh as CFO	20/20/20	CI
Geyser Brands Inc. Terminates Previously Entered Joint Venture with Factory Brewing Ltd	20/20/20	CI
Geyser Brands and Grow Academy Technologies Bring Pre-Legalization Cannabis Companies to Market	24/20/24	CI
Geyser Brands Inc. Announces 0957102 B.C. Ltd. DBA Apothecary Botanicals Awarded by Health Canada Its Full Sales License	23/20/23	CI
Geyser Brands Inc. Announces Strategic Partnership and Investment Agreement ('Agreement') with Hanma Investment Group	08/20/08	CI
Geyser Brands Inc. Receives Health Canada NPN Number for Its Eczema Topical Cream	26/20/26	CI
Geyser Brands Inc. Announces Board Appointments	27/20/27	CI
Geyser Brands Inc. Appoints Two Independent Directors	27/20/27	CI
Geyser Brands Inc. announced that it has received CAD 0.522 million in funding	15/20/15	CI

Geyser Brands Inc. is a Canada-based company, which builds brands in the health and wellness space that focus on the benefits of cannabis to improve lives. The Company's Health Canada approved licensed production facility has cultivation, processing, research, and sales licenses, allowing it to deliver delivery technologies, formulations, research partnerships and traceability in supply and distribution.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+7.30%	480.69Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	359.73Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	308.96Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	262.23Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	227.13Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	181.51Cr
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	141.17Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	137.88Cr
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	137.25Cr

Alternative Medicine